Gut feeling: can a probiotic lift depression?
NCT ID NCT07562516
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a probiotic called Bifidobacterium PB-18 can improve symptoms of mild to moderate depression in adults aged 18 to 65 who are not taking antidepressants. Participants will take either the probiotic or a placebo daily for 8 weeks. Researchers will measure depression scores, check for side effects, and explore how the gut-brain connection might be involved.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 88 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
Apr 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Outpatient or inpatient participants, aged 18 to 65 years (inclusive), of any sex * Current episode meets Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria for depressive disorder * Baseline score on the 17-Item Hamilton Depression Rating Scale is 7 to 24, inclusive * No concomitant use of antidepressants or other psychotropic medications during the study * Elementary school education or above, able to understand the study requirements and complete the rating scales * Participant personally signs the informed consent form and is willing to complete follow-up according to the study protocol Exclusion Criteria: * Current or past diagnosis, according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria, of bipolar disorder, schizophrenia spectrum and other psychotic disorders, neurocognitive disorders, neurodevelopmental disorders, or substance-related and addictive disorders * Presence of significant psychotic symptoms, such as delusions or hallucinations * Severe or unstable diseases of the central nervous system, cardiovascular system, respiratory system, liver, kidneys, endocrine system, hematologic system, or other systems that, in the investigator's judgment, make the participant unsuitable for the study * Evident suicide risk, defined as a score of 1 or higher on the suicide item of the 17-Item Hamilton Depression Rating Scale * Active inflammatory disease * Gastrointestinal infection, tumor, or other organic digestive disease, including but not limited to irritable bowel syndrome, Crohn disease, ulcerative colitis, or celiac disease * History of major gastrointestinal surgery * Use of antibiotics, probiotics, prebiotics, or related functional products within 1 month before study entry * Allergy to the study product or any of its components * Pregnant or breastfeeding women * Unable or unwilling to take the study product as required by the protocol * Any other condition that, in the investigator's judgment, makes the participant unsuitable for the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Depressive disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can brisk walking boost antidepressant results?
- Can a Brain-Signaling drug crack depression that resists standard treatment?
- Three questions may be enough to spot depression before surgery
- Can a gut supplement ease anxiety and depression in obesity?
- Can brain activity reveal why some people with depression lose motivation and pleasure?
- Can a brain zapping technique and online therapy fix sleep in depressed teens?